The SCARLET Trial: Radiotheranostics in Multiple Myeloma
- PMID: 41269133
- PMCID: PMC12670027
- DOI: 10.1148/rycan.259036
The SCARLET Trial: Radiotheranostics in Multiple Myeloma
References
-
- Delbart W , Karfis I , Vercruyssen M , et al . The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma . Eur J Nucl Med Mol Imaging 2025. . Published online August 28, 2025. doi: 10.1007/s00259-025-07500-y - DOI - PubMed
LinkOut - more resources
Full Text Sources
